BioMedTracker is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.


Report Library

All Reports
Datamonitor Healthcare CV&Met: Anemia in Chronic Kidney Disease Disease Coverage

Retail Price: $22,000.00

*BioMedTracker Subscriber Price: $15,000.00 - click here to log in

July 17, 2018

Chronic kidney disease (CKD) is characterized by decreased kidney function and kidney damage. Damaged renal tissue has a diminished ability to produce erythropoietin, a hormone that stimulates red blood cell production. Consequently, patients with CKD often experience anemia, defined as a reduction in red blood cells or hemoglobin levels. The risk of anemia increases as CKD progresses and kidney function declines.

This Datamonitor Healthcare Disease Coverage report contains Forecast, Treatment, Epidemiology, Marketed Drugs, and Pipeline modules.

Disease Group Covered: Hematology
Indications Covered: Alport Syndrome
End-Stage Renal Disease (ESRD)
Focal Segmental Glomerulosclerosis (FSGS)
Immunoglobulin A (IgA) Nephropathy (Berger's Disease)
Polycystic Kidney Disease
Renal Disease / Renal Failure
Renal Toxicity Due To Oncology Treatment
Back to the top Back to the top